Continued research into the functional implications of these mutations and their effects on TDP-43 dynamics is essential for developing targeted therapeutic strategies aimed at mitigating the consequences of TDP-43 pathology in ALS. Here, TARDBP is linked to amyotrophic lateral sclerosis.